April 15, 2020 | Reading Time: < 1 minute
The demand for access to less invasive biopsy methods for cancer presents a critical decision for many provider laboratories.
In this webinar, Mr. Brady Davis MBA and Dr. Anna Lapuk, outline the pros and cons for bringing plasma testing in-house vs. send out services for oncology testing, suggest when organizations might find the transition most beneficial, and outline the process for transitioning from send out to in-house testing.
Critical factors for consideration such as staffing, oncologist and pathologist outreach and education, LIMS and data ecosystem integration, and clinical reporting will be presented.
June 5, 2023
To discuss the development of the Endometrial ProMisE Molecular Classifier, and the new NSMP study further, we are delighted to have Dr. Jessica McAlpine and Dr. Amy Jamieson, esteemed gynecological cancer surgeons at Vancouver General Hospital, who have been instrumental in the development and implementation of this innovative tool.
May 15, 2023
We were grateful for the opportunity to attend and present at the AACR Annual Meeting last week, where three of our scientists highlighted some of the exciting work happening in our Vancouver lab.
March 28, 2023
Imagia Canexia Health announced that three abstracts highlighting the company’s new learnings and tools will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2023, taking place April 14-19, 2023, at the Orange County Convention Center in Orlando, Florida.